Prophylactic use of granulocyte colony-stimulating factor in breast cancer chemotherapy in china: A retrospective observational study
Pakistan Journal of Pharmaceutical Sciences · 17.11.2026
DOI: 10.36721/pjps/2026.40.16111.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, online erschienen am 17.11.2026. Verfasst von Lilian Hu. Die Arbeit nennt 18 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Febrile neutropenia (FN) is a serious complication of myelosuppressive chemotherapy. Clinical practice guidelines recommend risk-stratified prophylactic G-CSF therapy, which is indicated primarily for patients with a high risk of febrile neutropenia (FN >20%).Although G-CSF is widely used in clinical practice in China, it remains unclear whether this use aligns with guideline-recommended risk stratification, as few real-world studies have evaluated adherence.
Objectives
This study aimed to evaluate the appropriateness of prophylactic G-CSF use in hospitalized breast cancer patients and identify the gap between clinical practice and current guidelines.
Methods
In this single-center, retrospective observational study, we evaluated the prophylactic use of G-CSF according to FN risk category among breast cancer patients scheduled to receive myelosuppressive chemotherapy in hospitalized patients in China between January 2019 and December 2021.
Results
A total of 4,181 chemotherapy cycles from 630 breast cancer patients were documented. The overall rate of prophylactic G-CSF use was 53.1%. Among these, 1,963 cycles (46.9%) involved inappropriate prophylactic use, including 1,836 cycles (43.9%) with underuse, 101 cycles (2.4%) with overuse and 26 cycles (0.6%) with non-standard use.
Conclusion
This study reveals substantial inappropriate use of prophylactic G-CSF in Chinese breast cancer patients, primarily characterized by underuse in guideline-indicated scenarios.
Zitieren
APA
Hu, L. (2026). Prophylactic use of granulocyte colony-stimulating factor in breast cancer chemotherapy in china: A retrospective observational study. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps/2026.40.16111.1
Vancouver
Hu L. Prophylactic use of granulocyte colony-stimulating factor in breast cancer chemotherapy in china: A retrospective observational study. Pakistan Journal of Pharmaceutical Sciences. 2026. doi:10.36721/pjps/2026.40.16111.1
BibTeX
@article{Hu2026,
author = {Hu, Lilian},
title = {Prophylactic use of granulocyte colony-stimulating factor in breast cancer chemotherapy in china: A retrospective observational study},
journal = {Pakistan Journal of Pharmaceutical Sciences},
year = {2026},
doi = {10.36721/pjps/2026.40.16111.1}
}
EUVIMED